# 10.1021@np100840w.pdf

## Page 1



# Cytotoxic Clerodane Diterpenes from _Casearia rupestris_

Gerardo M. Vieira-Junior, Luiz A. Dutra, Paulo M. P. Ferreira, Manoel O. de Moraes, Leticia V. Costa Lotufo, Claudia do O Pessoa, Roseli Buzanelli Torres, Nivaldo Boralle, Vanderlan da S. Bolzani, Alberto J. Cavalheiro

###### Abstract

Four new clerodane diterpenes, caseaurepestrins A-D (1**-**4**), were isolated from the leaves of _Casearia rupestris_. Compounds **1** and **4** were acetylated to yield 2,7-di-O-acetylcaseaurepestrin A (**5**) and 2,6-di-O-acetylcaseaurepestrin D (**6**). All compounds were evaluated for cytotoxicity against a small panel of human cancer cell lines. Caseaurepestrin A (**1**) exhibited the most potent activity against MDA/MB-435 (human melanoma) and SF-295 (human glioblastoma) cells, superior to that of the standard drug doxorubicin.

## Introduction

The tropical genus _Casearia_ (_Salicaceae sensu lato_) contains ca. 180 species,1 and it is a rich source of clerodane-type diterpenes,2-13 The genus occurs widely in Brazil, where C. _sylvestris_ is the most frequent species, occurring from the Amazon basin throughout the Cerrado (savanna) to the Atlantic Forest and Southern Brazil. The clerodanes are a group of diterpenoids with interesting biological effects such as antifungal,14 antichismamial and antiplasmodal,15 antimalarial and antimyobacterium1,16 antitumor,17,18 cytotoxic,14,19,16-31 immunomodulatory,32 immunodulatory,32 and trypanodal activities.33 In our continuing investigation of the bioactive clerodane diterpenes from _Casearia_ species, we undertook the first phytochemical investigation of _Casearia rupestris_ Eichler. This shrub or small tree grows up to 6.0 m in height and is found in Brazil (Mato Grosso and Minas Gerais States) and Bolivia (Sta. Cruz State) in the Cerrado, grasslands, and sometimes pastures, at altitudes of 350-500 m.34 Investigation of the cytotoxic Et2O fraction yielded four new clerodane diterpenes (1**-**4**) (Figure 1). Compounds **1** and **4** were acetylated, resulting in two new derivatives (**5**, **6**) (Figure 1). The cytotoxic activity of the diterpenes (1**-**6**) against a panel of human cancer cell lines (HL-60, MDA/MB-435, HCT-8, and SF-295) has been evaluated.

## Results and discussion

Investigation of the Et2O phase of the EtOH extract of the leaves of C. _nupestris_ led to the isolation of four new clerodane diterpenoids, caseaurepestrins A-D (1**-**4**). 2,7-Di-O-acetylcaseaurepestrin A (**5**) and 2,6-di-O-acetylcaseaurepestrin D (**6**) were obtained by acetylation of compounds 1 and 4, respectively. The structures (Figure 1) of the compounds were elucidated on the basis of spectroscopic and spectrometric data (IR, UV, NMR, and MS) and by comparison with NMR data of reported compounds.6

Caseaurepestrin A (**1**) was obtained as a white, amorphous solid ([a]24D +4.3 (c 1.0, MeOH)). The molecular formula

## Page 2

C34H48O9 was determined by HRESIMS, based on the sodiated ion peak at _m_/_z_ 623.3190 \([\)M + Na\(]^{+}\) (calcd 623.3190), which implies 11 degrees of unsaturation. The IR spectrum showed the presence of carbonyl esters (1746 and 1712 cm-1). The UV spectrum displayed absorptions at _l_max 223 nm (log \(e\) 1.40) and 268 nm (log \(e\) 1.50), corresponding to diene and dienome chromophores, respectively. The 13C and DEPT 135deg NMR data showed the presence of 34 carbons divided into seven quaternary (including three carbonyl carbons), 13 methine, nine methylene, and five methyl carbons. The olefinic region of the 1H NMR spectrum of **1** (Table 1) revealed proton signals with characteristic _cis_/_trans_ coupling at \(d\)0 5.06 (1H, d, \(J\) = 10.5 Hz, H-15), 5.30 (1H, d, \(J\) = 17.5 Hz, H-15), and 6.47 (1H, dd, \(J\) = 10.5, 17.5 Hz, H-14), indicating a terminal monosubstituted olefinic moiety. Another terminal methylene, identified by two singlets at _d_H 4.94 and 5.03 (2H, H-16), was connected to a quaternary carbon (C-13). An additional olefinic doublet was observed at _d_H 6.04 (1H, d, \(J\) = 4.0 Hz, H-3) and correlated to a methine carbon at _d_C 128.6 (C-3) in the gHMQC spectrum. Two deshielded acid protons were observed at _d_H 6.35 (1H, t, \(J\) = 1.5 Hz, H-18) and 6.49 (1H, s, H-19), which correlated to methine signals at _d_C 96.3 and 99.8, respectively. The 1H NMR spectrum also revealed the presence of two methyl groups at _d_H 1.06 (1H, brd, \(J\) = 4.0 Hz, H-17) and 1.07 (1H, s, H-20) and three oxymethines at _d_H 4.45 (1H, brd, \(J\) = 4.0 Hz, H-2), 5.18 (1H, d, \(J\) = 10.0 Hz, H-6), and 3.66 (1H, t, \(J\) = 10.0 Hz, H-7). The spectroscopic data of 1 (Tables 1 and 2) are in accord with the basic skeleton of clerodane diteroprenoids previously isolated from _Cascaria_ species.10,18,35 The acyclic moiety at C-9, including the diene group, was deduced from the correlations of H-12 with C-11, H-14 with C-13 and C-16, H-15 with C-13 and C-14, and H-16 with C-14 (Figure 2). The position of the hydroxy group at C-7 was deduced by the long-range correlation of the oxymethine signal at _d_H 3.66 (H-7) with _d_C 77.5 (C-6), 44.8 (C-8), and 11.7 (C-17) (Figure 2). A decadienoate moiety, identified by gHMBC and gCOSY correlations (Figure 2), was characterized by a \(Z\) - (_d_H 5.68, \(J\) = 11.5 Hz; 6.69, \(J\) = 11.5 Hz) and an _E_-double bond (_d_H 7.37, \(J\) = 14.0, 11.5 Hz; 6.16, \(J\) = 14.0, 7.0 Hz) and a triplet methyl (_d_H 0.98, \(J\) = 7.0 Hz). This same 

## Page 3

19-epoxy-7-(['2/_Z_,_A_'_E_)-decadienoyloy]-2,6-dihydroxy-18-methoxy-yclero-3,13(16),14-triene.

Compound **4** had the molecular formula C36H50O10, determined by HRESIMS (observed _m_/_z_ 665.3297 [M + Na]+). The 1H and 13C NMR data of **4** (caseuarpestrin D) (Tables 1 and 2) were similar to those of **2** except for replacement of a hydroxy group at C-6 by an acetyone group [d1.195 (3H, s), d1C 171.5, d20.9]. The 1H and 13C NMR assignments of compound **4** were confirmed by 2D NMR correlations, and its configuration was established by the sign of the specific rotation, NOESY interactions, and coupling constants (Figure 3). Thus, caseuarpestrin D (**4**) was assigned as _rel_-(2R,S,S,6S,8R,9R,10S,18R,19R)-6,18, 19-triacetoxy-18,19-epoxy-7.[('2/_Z_,_A_'E_)-decadienoyloy]-2-hydro-yclero-3,13(16),14-triene.

Acetylation of **1** and **4** with d2O-pyridine yielded two new clerodane direprenes derivatives, **5** and **6**, respectively (Tables 1 and 2, NMR data). The products were named 2,7-di-O-acetylcaseuarpestrin A (**5**) and 2,6-di-O-acetylcaseuarpestrin D (**6**).

The results of the biological tests of compounds **1**-**6** are shown in Table 3. Caseuarpestrins A (**1**), B (**2**), and D (**4**) showed significant cytotoxicity against four cell lines (HL-60, HCT-8, MDA/MB-435, and SF-295), with IC50 values ranging from 0.10 to 1.3 _m_M. Compound **1** had an IC50 value of 0.36 _m_M against MDA/MB-435 and SF-295 cancer cell lines, superior to that of the standard drug doxorubicin (Table 3). Acetylation of compounds **1** and **4** resulted in decreased cytotoxicity (Table 3), indicating that the C-2 OH group is essential for the cytotoxicity of these compounds.

## EXPERIMENTAL SECTION

### General Experimental Procedures.

Optical rotations were measured on a Perkin-Elmer 341 LC polarimeter. UV spectra were measured on a Hewlett-Packard 8453 A spectrometer. The circular dichroism spectra were obtained on a JASCO PU-2089 HPLC system configured with a UV-vis (MD-2010) and a circular dichroism (CD-2095) detector. IR spectra were measured on a Nicolet Impact 400 spectrometer, using KBr disks. The 1D (1H, 13C, DEPT, and NOE)

\begin{table}
\begin{tabular}{c c c c c c c}   position & **1** & **2** & **3** & **4** & **5** & **6** \\
1 & 2.00 m & 1.34 m & 1.96 m & 2.10 m & 2.19 m & 2.08 m \\  & 2.06 m & 1.91 m & & & & 2.17 m \\
2 & 4.45 brt (4.0) & 4.39 brt (4.0) & 4.37 brt (4.0) & 4.35 brt (4.0) & 5.55 m & 5.52 m \\
3

## Page 4

and 2D (\({}^{1}\)H-1\({}^{1}\)HgCOSY, \({}^{1}\)H-1\({}^{3}\)C gHMQC, gHMBC, and gNOSSY) NMR experiments were recorded on a Varian INOVA 500 spectrometer (11.7 T) at 500 MHz (\({}^{1}\)H) and 125 MHz (\({}^{13}\)C) with pulse field gradient and a Varian INOVA 300 spectrometer (7.4 T) at 300 MHz (\({}^{1}\)H) and 75 MHz (\({}^{13}\)C), using methanol-\(d_{4}\) as the internal standard for \({}^{13}\)C NMR chemical shifts and residual undeuterated solvent (methanol) as the internal standard for \({}^{1}\)H NMR, with the \(\delta\) scale reported relative to TMS. Positive-ion HRMS spectra were recorded on an UltraOTOFq (Bruker Daltonics) ESI-qTOF mass spectrometer, using TFANa as the internal standard. Analytical HPLC was performed on a Varian Pro Star 230 with UV-vs detector (model 330), using a Phenomence C18 column (250 mm x 4.6 mm, 5 \(\mu\)m). Open column chromatography was performed over silica gel (40-63 \(\mu\)m, Merck) or silica C18 (40 \(\mu\)m, J. T. Baker) or on Sephadex LH-20 (Pharmacia Biotech). TLC was performed using Merck silica gel 60 (>230 mesh) and precoated silica gel 60 PF354 plates. Spots on TLC plates were observed under UV light and by spraying the plates with anisaldehyde\(-\)H2SO4 reagent, followed by heating at 120 degC.

Plant Material. _Casesaria rupstris_ leaves were collected in May 2007 in Campinas municipality, Saio Paulo State, Brazil. The plant material was identified by one of the authors (R.B.T.). A voucher specimen (IAC41542) has been deposited in the herbarium of the Instituto Agronomico de Campinas (Sao Paulo State).

### Extraction, Isolation, and Chemical Transformation.

The dried and ground leaves (0.46 kg) were exhaustively extracted by successive macration with hexanes, EtOH, and H2O (3.0 L x 3) at room temperature. The EtOH extract was concentrated under reduced pressure at 40 degC to yield 30.0 g of a crude extract. This extract was then diluted with MeOH\(-\)H2O (3:1) and successively partitioned with hexanes (1.0 L x 3), Et2O (1.0 L x 3), and Et2OAc (1.0 L x 3). After removal of the solvent, each extract yielded 10.8, 3.2, and 1.2 g, respectively. Part of the cytotoxic Et2O (3.0 g) fraction was subjected to gel permeation chromatography on Sephadex LH-20 (78.0 x 3.0 cm) eluted with MeOH, to afford 38 fractions. These fractions were combined on the basis of their TLC profiles. Fraction 12 (1.7 g) was subjected to column chromatography (silica gel-C18, 78.0 x 3.0 cm,

\begin{table}
\begin{tabular}{c c c c c c c} position & 1 & 2 & 3 & 4 & 5 & 6 \\
1 & 30.6, CH2 & 30.6, CH2 & 30.6, CH2 & 30.5, CH2 & 27.8, CH2 & 27.8, CH2 \\
2 & 64.2, CH & 64.2, CH & 64.3, CH & 64.0, CH & 67.5, CH & 67.4, CH

## Page 5

40 \(\mu\)m) using a step gradient from H2O\(-\)MeOH 23:77 to 00:100, yielding 55 fractions. Fraction 14 (175.0 mg) was subjected to silica gel column chromatography (21.8 x 2 cm, 230\(-\)400 mesh) eluted with hexane\(-\)EtOAc (6:4), to yield compound 1 (7.9 mg). Fraction 30 (88.0 mg) was subjected to silica gel column chromatography (21.8 x 2 cm, 40\(-\)63 \(\mu\)m) eluted with hexane\(-\)EtOAc (4:6) to yield compound 2 (13.0 mg). Fraction 34 (150.5 mg) was subjected to silica gel column chromatography (21.8 x 2 cm, 40\(-\)63 \(\mu\)m) eluted with hexane\(-\)EtOAc (1:1) to yield compound 3 (10.0 mg). Finally, fraction 36 (356.0 mg) was subjected to silica gel column chromatography (21.8 x 2 cm, 40\(-\)63 \(\mu\)m) eluted with hexane\(-\)EtOAc (1:1) to yield compound 4 (212.0 mg). Compounds 1 and 4 (20 mg each) were dissolved in pyridine (4.0 mL) and treated with AcO(3.0 mL) at room temperature for 24 h. The solvents were removed by evaporation under reduced pressure, resulting in compounds 5 (18.0 mg) and 6 (18.0 mg).

_Cosequercetin A (1_): White, amorphous solid; [o]24 +-3 (_c_ 0.1, CHCl3); UV \(\lambda_{\text{max}}^{\text{MOH}}\) (nm (_log_c_) \(2\)23 (1.40), 268 (1.50)). CD (_c_ 0.02, MeOH) _Δ_ (_m_) +-6 (223), +-6 (268); IR (KBr) \(v_{x}\) cm-1 3434, 2959, 2932, 1746, 1712, 1378, 1230, 1028; \({}^{\text{H}}\) and \({}^{\text{3}}\)C NMR (methanol-_d_4), see Tables 1 and 2, respectively; HRTOF-ESIMS _m/z_ 623.3190 [M + Na]\({}^{+}\) (caled for C34H8O3Na,623.3190).

_Cosequercetin B (2_): white, amorphous solid; [o]24 +-76 (_c_ 0.1, CHCl3); UV \(\lambda_{\text{max}}^{\text{MOH}}\) (nm (_log_c_) \(2\)23 (1.48), 268 (1.55)). CD (_c_ 0.03, MeOH) _Δ_ (_m_) +-5 (423), +-6 (268); IR \(v_{x}\) cm-1 3436, 1746, 1712, 1636, 1177, 1000, 900; \({}^{\text{H}}\) and \({}^{\text{3}}\)C NMR (methanol-_d_4), see Tables 1 and 2, respectively; HRTOF-ESIMS _m/z_ 623.3206 [M + Na]\({}^{+}\) (caled for C34H8O3Na,623.3190).

_Cosequercetin C (2_): White, amorphous solid; [o]20 +-72 (_c_ 0.1, CHCl3); UV \(\lambda_{\text{max}}^{\text{MOH}}\) (nm (_log_c_) \(2\)23 (1.43), 268 (1.48)); CD (_c_ 0.03, MeOH) _Δ_ (_m_) +-5 (223), +-5 (268); IR \(v_{x}\) cm-1 3436, 1746, 1746, 1746, 1746, 1746, 1746, 1746, 1746, 1746, 1746, 1746 NMR (methanol-_d_4), see Tables 1 and 2, respectively; HRTOF-ESIMS _m/z_ 6653.2397 [M + Na]\({}^{+}\) (caled for C34H8O3Na,665.3296).

_2,7-Di-O-acetylcosequercetin A (5):_ colorless oil; [o]25 +-56 (_c_ 0.1, MeOH); UV \(\lambda_{\text{max}}^{\text{MOH}}\) (nm (_log_c_) \(2\)23 (1.43), 268 (1.60)); IR \(v_{x}\) cm-1 3454, 2953, 1752, 1374, 1227, 1026; \({}^{\text{H}}\) and \({}^{\text{3}}\)C NMR (methanol-_d_4), see Tables 1 and 2, respectively; HRTOF-ESIMS _m/z_ 707.3401 [M + Na]\({}^{+}\) (caled for C34H8O3Na,703.73401 [M + Na]\({}^{+}\) (caled for C34H8O3Na,703.73401 [2.6-O]-_d_4), see Tables 2-Di-O-acetylcosequercetin D (6): colorless oil; [o]25 +-99 (_c_ 0.1, MeOH); UV \(\lambda_{\text{max}}^{\text{MOH}}\) (nm (_log_c_) \(2\)23 (1.46), 268 (1.55)); IR \(v_{x}\) cm-1 34

## Page 6



## Author Information

### Corresponding Author

"Tel: + 55 16 33016667. Fax: 55 16 33227932. E-mail: cavalheiro_alberto@yahoo.com.br.

## Acknowledgment

The authors are grateful to the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and the biota Instituto Virtual da Biodiversidade for financial support of Project No. 03/02176-7. We are grateful to Prof. Dr. W. Vilegas for the use of the polarimeter, UV, IR, and HPLC with circular dichroism detector. Finally, we thank Prof. Dr. N. Peporine Lopes for the use of the LC-MS.

## References

* Shen et al. 2004 Shen, Y.-C.; Wang, C.-H.; Cheng, Y.-B.; Wang, L.-T.; Guh, J.-H.; Chien, C.-T.; Khalil, A. T. J. Nat. Prod.**2004**, _67_, 316-321.
* Carvalho et al. 1998 Carvalho, P. R. F.; Furlan, M.; Young, M. C. M.; Kingston, D. G. I.; Bolani, V. D. S. Phytochemistry**1998**, _49_, 1659-1662.
* Khan et al. 1990 Khan, M. R.; Gray, A. I.; Reed, D. R.; Sadler, I. H.; Waterman, P. G. Biochemistry**1990**, _29_, 3591-3595.
* Chen et al. 1991 Chen, T. B.; Viemer, D. F. J. Nat. Prod.**1991**, _54_, 1612-1618.
* Gibbons et al. 1986 Gibbons, S.; Gray, A.; Waterman, P. G. Phytochemistry**1996**, _41_, 565-570.
* Guttnet et al. 1988 Guttnet, E.; Stoven, V.; Lallemand, J.; Ramiandrasoa, F.; Kunesch, G. Tetrahedron**1988**, _44_, 2893-2901.
* Mosadik and Waterman 2006 Mosadik, M. A.; Waterman, P. G. A. Nat. Prod. Commun.**2006**, \(1\), 601-607.
* Mosadik et al. 2006 Mosadik, M. A.; Forster, P. I.; Booth, R.; Waterman, P. G. A. Nat. Prod. Commun.**2006**, \(1\), 441-448.
* Mosadik et al. 2007 Mosadik, M. A.; Forster, P. I.; Booth, R.; Waterman, P. G. A. Biochem. Syst. Ecol.**2007**, _35_, 631-633.
* Santos et al. 2007 Osmats, A. G.; Perez, C. C.; Tinnins, A. G.; Bolani, V. S.; Cavalheiro, A. J. Quim. Nov.**2007**, _30_, 1100-1103.
* Santos et al. 2010 C. C.; Tinnins, A. G.; Ferreira, P. M. P.; Vieira-Junior, G. M.; Perez, C. C.; Tinnins, A. G.; Silva, G. H.; Bolani, V. S.; Costa-Lotufo, L. V.; Pessoa, C. O.; Cavalheiro, A. J. Chem. Biochemistry**2010**, \(7\), 205-215.
* Shen et al. 2005 Shen, Y.-C.; Cheng, Y.-B.; Chen, Y.-H.; Khalil, A. T.; Ko, C.-L. J. Chin. Chem. Soc.**2005**, _52_, 1263-1268.
* Vijayakumar et al. 2002 Vijayakumar, E. K. S.; Bal-Tembe, S.; Joshi, K. S.; Deere, V. B. _Indian J. Chem., Sec. B: Org. Chem. Ind. Med. Chem._**2002**, _41_, 2706-2708.
* Oberlies et al. 2002 Oberlies, N. H.; Burgess, J. P.; Navarro, H. A.; Pinos, R. E.; Fairchild, C. R.; Peterson, R. W.; Soejarto, D. D.; Farnsworth, N. R.; Kinghorn, A. D.; Wani, M. C.; Wall, M. E. J. Nat. Prod.**2002**, _65_, 95-99.
* Jullan et al. 2005 Jullan, V.; Bondulele, C.; Valentin, A.; Acebe, L.; Duigou, A.-G.; Prevost, M.F.; Sauvan, M. Biogge. Med. Chem. Lett**2005**, _15_, 5065-5070.
* Kankochmakul et al. 2005 Kankochmakul, S.; Kankos, T.; Buayarinskas, M. J. Nat. Prod.**2005**, _68_, 183-188.
* Itokawa et al. 1988 Itokawa, H.; Totsuka, N.; Morita, H.; Takeya, K.; Watanabe, K.; Obata, E. Chem. Pharm. Bull.**1988**, _36_, 1585-1588.
* Itokawa et al. 1990 Itokawa, H.; Totsuka, N.; Morita, H.; Takeya, K.; Iraka, Y.; Schenkel, E. P.; Miodome, M. Chem. Pharm. Bull.**1990**, _38_, 3384-3388.
* Beutler et al. 2000 Beutler, J. A.; MacCall, K. L.; Herbert, K.; Herald, D. L.; Pettit, G. R.; Johnson, T.; Shoemaker, R. H.; Boyd, M. R. J. Nat. Prod.**2000**, _63_, 657-661.
* Beutler et al. 2000 Beutler, J. A.; MacCall, K. L.; Herbert, K.; Johnson, T.; Shoemaker, R. H.; Boyd, M. R. Phytochemistry**2000**, _55_, 233-236.
* Chen et al. 2008 Chen, C.-Y.; Cheng, Y.-B.; Chen, S.-Y.; Chien, C.-T.; Kuo, Y.-H.; Guh, J.-H.; Khalil, A. T.; Shen, Y.-C. Chem. Biodiversity**2008**, \(5\), 162-167.
* Kanokmehakul et al. 2007 Kanokmehakul, S.; Kankochmakul, K.; Buayarinskas, M. J. Nat. Prod.**2007**, _70_, 1122-1126.
* Hayashi et al. 2002 Hayashi, K.-I.; Nakanishi, Y.; Bastow, K. F.; Cragg, G.; Nozaki, H.; Lee, K.-H. _Bioorg. Med. Chem. Lett._**2002**, _12_, 345-348.
* Oberlies et al. 2001 Oberlies, N. H.; Burgess, J. P.; Navarro, H. A.; Pinos, R. E.; Soejarto, D. D.; Farnsworth, N. R.; Kinghorn, A. D.; Wani, M. C.; Wall, M. E. J. Nat. Prod.**2001**, _64_, 497-501.
* Prakash et al. 2002 Prakash, C. V. S.; Hoch, J. M.; Kingston, D. G. I. J. Nat. Prod.**2002**, _65_, 100-107.
* Shen et al. 2004 Shen, Y.-C.; Wang, L.-T.; Wang, C.-H.; Khalil, A. T; Guh, J.-H. _Chem. Pharm. Bull._**2004**, _52_, 108-110.
* Shen et al. 2005 Shen, Y.-C.; Cheng, Y.-B.; Ahmed, A. F.; Lee, C. L.; Chen, S.-Y.; Chien, C.-T.; Kuo, Y.-H.; Tzeng, G.-L. J. Nat. Prod.**2005**, _68_, 1665-1668.
* Shen et al. 2005 Shen, Y.-C.; Lee, C. L.; Khalil, A. T.; Cheng, Y.-B.; Chien, C.-T.; Kuo, Y.-H. _Helv. Chim. Acta_**2005**, _88_, 68-77.
* Vieira-Junior et al. 2009 Vieira-Junior, G. M.; Goncalves, T. O.; Regasini, L. O.; Ferreira, P. M. P.; Pessoa, C. O; Costa-Lotufo, L. V.; Torres, R. B.; Boralle, N. B.; Bolzani, V. S.; Cavalheiro, A. J. Nat. Prod.**2009**, _72_, 1847-1850.
* Williams et al. 2007 Williams, R. B.; Norris, A.; Miller, J. S.; Birkinshaw, C.; Ratovoson, F.; Andrianfarana, R.; Rasamison, V. E.; Kingston, D. G. I. J. Nat. Prod.**2007**, _70_, 206-209.
* Ferreira et al. 2010 Ferreira, P. M. P.; Santos, A. G.; Tinnins, A. G.; Costa, P. M.; Cavalheiro, A. J.; Bolzani, V. S.; Moraes, M. O.; Costa-Lotufo, L. V.; Montenegro, R. C.; Pessoa, C. O. Chem.-Biol. Interact.**2010**, _188_, 497-504.
* Hunter et al. 1997 Hunter, M. S.; Corley, D. G.; Carron, C. P.; Rowold, E.; Kilpatrick, R. F.; D'alvez, R. C. J. Nat Prod.**1997**, _60_, 894-899.
* Espindola et al. 2004 Espindola, L. S.; Vasconcelos Junior, J. R.; Mesquita, M. L.; Marquie, P.; Paula, J. E.; Mambu, L.; Santana, J. M. Planta Med.**2004**, _70_, 1093-1095.
* Sleumer 1980 Sleumer, H. O. Flora Netropica; The New York Botanical Garden: New York, 1980; pp 1 -499.
* Morita et al. 1991 S. Morita, H.; Nakayama, M.; Kojima, H.; Takeya, K.; Itokawa, H.; Schenkel, E. P.; Miodome, M. Chem. Pharm. Bull.**1991**, _39_, 693-697.
* Whitson et al. 2010 Whitson, E. L.; Thomas, C. L.; Henrich, C. J.; Sayers, T. J.; McMahon, J. B.; McKee, T. C. J. Nat. Prod.**2010**, _73_, 2013-2018.
* Mosmann 1983 Mosmann, T. J. Immunol. Methods**1983**, _16_, 55-63.



